'The Sky's The Limit' When It Comes To Device Reimbursement Reforms, White House Official Says
Executive Summary
The top health official at the White House Office of Management and Budget says the Trump administration is committed to clearing barriers that stand in the way of reimbursement for new medical technology. “We’re doing a lot of work on medical device stuff that nobody knows about, trying to figure out how America can maintain our dominance," Joe Grogan said Sept. 20.
You may also be interested in...
Into 2019: Digital Leads US Policy Innovations, But Public Medtech Scrutiny Grows
Scott Gottlieb's FDA continues to push out policy reforms and experiments at a rapid pace, with special focus on digital and AI technologies. In parallel, US Medicare officials are more publicly signaling plans to roll out policies for a quicker path to reimbursement for new devices. However, public scrutiny of whether device regulations properly protect patient safety is growing, and it could have an impact.
Medicare Looks To Speed Local Coverage Process For Medtech
The US Centers for Medicare and Medicaid Services has revised its local coverage determination manual to make the LCD process more transparent and responsive to the public. It’s intended as a first step to improving reimbursement processes for innovative therapies and devices, Medicare Chief Seema Verma said.
CMS Actively Looking For New Reimbursement Pathway For Innovative Devices
Industry is looking for a policy by the end of the year that would provide an automatic, temporary coverage pathway for breakthrough devices, and federal officials, including from the US Centers for Medicare and Medicaid Services (CMS) acknowledge they are actively looking at options for improving device reimbursement.